Everest Medicines - Ownership and Business Overview

Life ScienceCompany

Everest Medicines Ownership

Who owns Everest Medicines?

.

Everest Medicines Business Overview

Where is Everest Medicines headquartered?

Everest Medicines is headquartered in New York, New York.

What sector is Everest Medicines in?

Everest Medicines is a life science company.

When was Everest Medicines founded?

Everest Medicines was founded in 2017.

Life Science M&A Summary in

Join Mergr to view all 0 acquisitions of life science companies in , including .

Everest Medicines

Everest Medicines Ltd.

450 Lexington Ave., 39B,
New York, New York 10017
United States,
www.everestmedicines.com

Everest Medicines is a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Greater China and other Asian markets. Everest Medicines was founded in 2017 and is based in New York.


 Subscribe to unlock this and 207,877
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.